Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,500
Closed -$1.09M 179
2024
Q2
$1.09M Sell
3,500
-10,700
-75% -$3.14M 0.2% 86
2024
Q1
$4.04M Buy
14,200
+6,100
+75% +$1.78M 0.13% 47
2023
Q4
$2.33M Buy
8,100
+3,900
+93% +$1.06M 0.09% 106
2023
Q3
$1.13M Buy
4,200
+1,500
+56% +$374K 0.09% 158
2023
Q2
$599K Buy
2,700
+1,500
+125% +$348K 0.03% 218
2023
Q1
$290K Sell
1,200
-6,000
-83% -$1.47M 0.01% 322
2022
Q4
$1.89M Buy
+7,200
New +$1.93M 0.18% 102
2019
Q3
Sell
-15,400
Closed -$52K 238
2019
Q2
$52K Buy
15,400
+5,100
+50% +$913K 0.01% 179
2019
Q1
$83K Buy
+10,300
New +$1.97M 0.01% 179

Other funds holding AMGN

XR Securities's AMGN Position: Q2 2024 in Review

XR Securities sold out of Amgen (AMGN) in Q2 2024, closing a stake of 14,357 shares — an estimated $4.22M sold.

XR Securities first reported a position in AMGN in Q2 2018 and held it in 8 quarters. The position peaked at $4.08M in Q1 2024. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

  • XR Securities reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
  • XR Securities sold 14,357 Amgen shares in Q2 2024, an estimated $4.22M.
  • XR Securities first reported a position in Amgen in Q2 2018 and held it in 8 quarters.
  • XR Securities's Amgen position peaked at $4.08M in Q1 2024.
  • 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on XR Securities's 13F filing for Q2 2024, filed 5 Aug 2024.